As a leader in the 503B sterile outsourcing market, Quva Pharma was purpose built to change the 503B industry for the better, and our name is an expression of our commitment to being the perfect blend of Quality and InnoVation.

That commitment has been unwavering as we continue to invest and expanded our 503B platform to include industry-first remote direct distribution capabilities and state of the art production facilities, and through our acquisition of the A.I. and predictive analytics data and software company BrightStream Health in July 2024.

Our Mission:

 Committed to enabling healthcare providers the ability to make informed decisions by providing high quality and effective medications, services, and solutions to facilitate efficient and accurate delivery of patient care.

In healthcare, every moment matters. Behind every treatment plan and every patient interaction lies an intricate web of operational and clinical decisions that shape the delivery of high- quality care. At Quva, we recognize that true healthcare excellence demands more than providing the highest quality medicines and reliable service-it requires a deep understanding of the entire healthcare ecosystem and the courage to reimagine what's possible.